CME GroupCME +0.23%80 Forward PE Ratio is 19.60 as of Jul. 12, 2026. GuruFocus rates CME with a GF Score™ of 80/100 and a GF Value™ of $271.41 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 221 Capital Markets companies, CME Group ranks worse than 65.16% on this metric.
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
CME Group Forward PE Ratio Related Terms
CME Group Forward PE Ratio Historical Data
* Premium members only.
The historical data trend for CME Group's Forward PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CME Group Forward PE Ratio Chart
CME Group Annual Data
Trend
2015-12
2016-12
2017-12
2018-12
2019-12
2020-12
2021-12
2022-12
2023-12
2024-12
2025-12
Forward PE Ratio
21.10
24.21
27.32
25.32
27.10
27.32
31.65
20.12
22.78
22.43
23.76
CME Group Quarterly Data
2015-12
2016-03
2016-06
2016-09
2016-12
2017-03
2017-06
2017-09
2017-12
2018-03
2018-06
2018-09
2018-12
2019-03
2019-06
2019-09
2019-12
2020-03
2020-06
2020-09
2020-12
2021-03
2021-06
2021-09
2021-12
2022-03
2022-06
2022-09
2022-12
2023-03
2023-06
2023-09
2023-12
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
2025-12
2026-03
Forward PE Ratio
21.10
19.80
22.42
21.98
24.21
24.57
25.84
25.51
27.32
25.38
24.15
23.81
25.32
22.94
28.41
28.65
27.10
22.37
21.55
23.04
27.32
32.15
32.26
27.55
31.65
33.33
26.67
21.28
20.12
23.09
21.19
21.93
22.78
22.52
20.37
21.41
22.43
24.65
24.56
23.27
23.76
24.29
CME vs MCO, ICE, NDAQ: Forward PE Ratio Comparison
For the Financial Data & Stock Exchanges subindustry, CME Group's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CME Group Forward PE Ratio vs Capital Markets Industry
For the Capital Markets industry and Financial Services sector, CME Group's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where CME Group's Forward PE Ratio falls into.
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
CME Group (CME) has a Forward PE Ratio of 19.60 as of Jul. 12, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on CME Group and its competitors. According to the industry distribution chart, CME Group ranks #144 out of 221 companies in the Capital Markets industry, placing it in the top 65.2%.
Is CME Group's Forward PE Ratio too high?
CME Group's current Forward PE Ratio is 19.60. The Capital Markets industry median Forward PE Ratio is 16.35. CME Group's value of 19.60 is 19.9% above this industry median. Based on the distribution chart, CME Group ranks #144 out of 221 companies in the Capital Markets industry, which is below the industry midpoint. Overall, CME Group has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CME Group's Forward PE Ratio compare to MCO and ICE?
According to the Capital Markets industry distribution chart, CME Group ranks #144 out of 221 companies for Forward PE Ratio. This places CME Group in the lower half of its industry. The industry median Forward PE Ratio is 16.35. CME Group's value of 19.60 is 19.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Capital Markets company?
The median Forward PE Ratio among Capital Markets companies is 16.35, based on 221 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CME Group's current Forward PE Ratio of 19.60 is 19.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on CME Group and its competitors. For the Capital Markets industry, the median Forward PE Ratio is 16.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CME Group's current Forward PE Ratio is 19.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CME Group stock overvalued right now?
Based on GuruFocus' analysis, CME Group (CME) is currently considered Modestly Undervalued. The stock's GF Value™ is $271.41, compared to a current price of $240.27 — trading 11.5% below its estimated fair value. The current Forward PE Ratio is 19.60 and 19.9% above the Capital Markets industry median of 16.35. CME Group's overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For CME Group (CME), the current Forward PE Ratio is 19.60 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CME Group (CME) Overvalued in 2026?
Based on GuruFocus' analysis, CME Group stock appears to be undervalued.
The current stock price of $240.27 is trading 11.5% below its estimated GF Value™ of $271.41.
GuruFocus considers CME Group to be Modestly Undervalued.
Key valuation signals for CME:
Forward PE Ratio: 19.60
GF Value™: $271.41 vs. price of $240.27 (11.5% below fair value)
Industry Position: 19.9% above the Capital Markets median (#144 of 221)
No single metric tells the full story. See the CME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indexes, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
80GF Score
Get the complete analysis for CME
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CME has been successfully added to your 